SCHEMBL23758263

SCHEMBL23758263

O=C(Nc1ccc(-c2c[nH]c(-c3ccccc3)n2)cc1)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.55
ADORA2A P29274 1/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
NPC1 O15118 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
HPGD P15428 1/20 0.55
CYP2C19 P33261 1/20 0.55
HTT P42858 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
BCHE P06276 1/20 0.51
ACHE P22303 1/20 0.51
PRKD3 O94806 1/20 0.51
MAP4K4 O95819 1/20 0.51
EGFR P00533 1/20 0.51
NTRK1 P04629 1/20 0.51
LCK P06239 1/20 0.51
FYN P06241 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31679102 0.99 ADORA3 (0.54) ADORA3ADORA2AMEN1KMT2ANPC1
SCHEMBL23758260 0.91 PTPN1 (0.58) MEN1KMT2ASMN1; SMN2HPSEMMP2
Hydrochloric Acid SCHEMBL31679076 0.90 PTPN1 (0.56) ADORA3ADORA2AMEN1KMT2ASMN1; SMN2
SCHEMBL23758258 0.89 KMT2A (0.62) ADORA3ADORA2AMEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL31679106 0.88 KMT2A (0.61) ADORA3ADORA2AMEN1KMT2ANPC1
SCHEMBL23758262 0.86 GSK3B (0.56) MEN1KMT2ANPC1SMN1; SMN2L3MBTL1
SCHEMBL23758265 0.85 RAB9A (0.59) ADORA3MEN1KMT2ANPC1SMN1; SMN2
SCHEMBL3136907 0.82 NR1H2 (0.51) MEN1KMT2ANPC1KDM4EALDH1A1
SCHEMBL3140919 0.82 NR1H2 (0.51) MEN1KMT2ANPC1KDM4EALDH1A1
SCHEMBL23812443 0.81 XDH (0.53) MEN1KMT2ANPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11090289-B2 Compositions and methods for blocking sodium channels UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2021-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11090289-B2 Compositions and methods for blocking sodium channels SCN3A, SCN1B, SCN2B ADORA3 832/4885ADORA2A 1805/4885MEN1 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.